HLA-A and prostate carcinoma: To our knowledge, only one previous study [56] involved experiments similar to ours; those authors reported biomarkers that predicted the outcome of vaccination with four kinds of HLA-A-restricted peptides in patients with conventional therapy-resistant prostate cancer.